RFO
CME icon

RiverGlades Family Offices’s CME Group CME Stock Holding History

RiverGlades Family Offices’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$216K Hold
800
– – 0.13% 88
2025
Q2 		$220K Sell
800
-900
-53% -$245K 0.14% 82
2025
Q1 		$451K Hold
1,700
– – 0.32% 52
2024
Q4 		$395K Hold
1,700
– – 0.28% 56
2024
Q3 		$375K Hold
1,700
– – 0.27% 59
2024
Q2 		$334K Buy
1,700
+600
+55% +$124K 0.26% 59
2024
Q1 		$235K Buy
+1,100
New +$231K 0.19% 71

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RiverGlades Family Offices's CME Position: Q3 2025 in Review

RiverGlades Family Offices held its CME Group (CME) position steady in Q3 2025 at 800 shares worth $216K. The position accounts for 0.13% of the portfolio, ranked #88.

RiverGlades Family Offices first reported a position in CME in Q1 2024 and has held it in 7 quarters since. The position peaked at $451K in Q1 2025. 1,650 funds tracked by Wall St. Rank hold CME as of Q3 2025.

  • RiverGlades Family Offices held 800 shares of CME Group worth $216K as of Q3 2025.
  • RiverGlades Family Offices left its CME Group share count unchanged in Q3 2025.
  • CME Group made up 0.13% of RiverGlades Family Offices's portfolio in Q3 2025, its #88 holding.
  • RiverGlades Family Offices first reported a position in CME Group in Q1 2024 and has held it in 7 quarters since.
  • RiverGlades Family Offices's CME Group position peaked at $451K in Q1 2025.
  • 1,650 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on RiverGlades Family Offices's 13F filing for Q3 2025, filed 12 Nov 2025.